Funding · Sep 16, 2026 · as investor
ByteDance-spun-off AI drug discovery firm Anew Labs raises US$290M in first independent round
Three months after ByteDance spun off its AI drug discovery unit as Anew Labs, the company has closed a $290M first independent financing round (RMB 2.03B). Investors include Sequoia Capital China, IDG Capital, GL Ventures (Hillhouse), 5Y Capital, and Gaorong Capital, along with several unnamed domestic pharmaceutical groups as strategic backers. What the proceeds will fund was not disclosed.
Original sources (Chinese)
“Anew Labs”完成2.9亿美元融资，红杉中国等参与投资周鸿祎：不会再投资新能源汽车，已经吃过一次亏；OpenAI洽谈新融资，估值或超1.2万亿美元；花呗、抖音月付等将退出支付选项？多平台回应Anew Labs已完成 2.9 亿美元融资，红杉中国、高瓴、IDG、五源、高榕等参与AI制药独角兽Anew单飞，字节推了一把“最烧钱的慢生意”AI制药一级热